Differences in brain aging between sexes in Parkinson’s disease

Iman Beheshti,Samuel Booth,Ji Hyun Ko

DOI: https://doi.org/10.1038/s41531-024-00646-w

2024-02-14

Abstract:Abstract Parkinson’s disease (PD) is linked to faster brain aging. Male sex is associated with higher prevalence, severe symptoms, and a faster progression rate in PD. There remains a significant gap in understanding the function of sex in the process of brain aging in PD. The structural T1-weighted MRI-driven brain-predicted age difference (i.e., Brain-PAD: the actual age subtracted from the brain-predicted age) was computed in a group of 373 people with PD (mean age ± SD: 61.37 ± 9.81, age range: 33–85, 34% female) from the Parkinson’s Progression Marker Initiative database using a robust brain-age estimation framework that was trained on 949 healthy subjects. Linear regression models were used to investigate the association between Brain-PAD and clinical variables in PD, stratified by sex. Males with Parkinson’s disease (PD-M) exhibited a significantly higher mean Brain-PAD than their female counterparts (PD-F) ( t (256) = 2.50, p = 0.012). In the propensity score-matched PD-M group (PD-M*), Brain-PAD was found to be associated with a decline in general cognition, a worse degree of sleep behavior disorder, reduced visuospatial acuity, and caudate atrophy. Conversely, no significant links were observed between these factors and Brain-PAD in the PD-F group. Having ‘older’ looking brains in PD-M than PD-F supports the idea that sex plays a vital function in PD, such that the PD mechanism may be different in males and females. This study has the potential to broaden our understanding of dissimilarities in brain aging between sexes in the context of PD.

neurosciences

What problem does this paper attempt to address?

The paper primarily explores the differences in brain aging between different genders in patients with Parkinson's disease (PD) and attempts to address the following key questions:

1. **The impact of gender differences on Parkinson's disease**: The study focuses on whether there are significant differences in clinical manifestations, symptom severity, and the rate of brain aging between male and female patients with Parkinson's disease.

2. **Application of Brain-Predicted Age Difference (Brain-PAD)**: By using machine learning techniques to estimate an individual's brain age and calculating the gap between the actual age and the predicted brain age (i.e., Brain-PAD), the study assesses whether the accelerated brain aging is associated with Parkinson's disease.

3. **Gender-specific associations**: The research aims to explore whether the acceleration of brain aging is associated with the pathological mechanisms of Parkinson's disease in a gender-specific manner, particularly in terms of clinical symptoms, cognitive function, emotional state, etc.

Specifically, the study found that the average Brain-PAD of male Parkinson's disease patients is significantly higher than that of female patients, indicating that brain aging may be faster in males. Additionally, the study analyzed the relationship between brain structural changes, cognitive function, emotional state, and Brain-PAD, and explored the differences in these associations between genders.

In summary, this research attempts to further understand how gender differences affect the progression and clinical manifestations of Parkinson's disease by analyzing the relationship between brain aging and Parkinson's disease. This has important implications for the future development of personalized treatment strategies.